Literature DB >> 25957808

Ten advances defining sudden cardiac death.

Raul D Mitrani1, Robert J Myerburg2.   

Abstract

Recent advances in the field of sudden cardiac death (SCD) include the recognition that 50% of SCD occurs as initial presentation of any heart disease and that many of these individuals may have been considered to be low risk. The presenting dysrhythmia in patients with cardiac arrests has changed over time such that pulseless electrical activity and asystole is more frequently encountered as compared with ventricular tachyarrhythmias. While the use of implantable defibrillators has been a tremendous advance in patients at risk for ventricular tachyarrhythmias, the use of automatic external defibrillators and wearable defibrillators is a recent advance that allows for potential SCD prevention in more patients. Finally, the area of medical genetics is an evolving discipline, which may enable clinicians to better individualize therapy for patients with genetic predispositions to cardiac dysrhythmias.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25957808     DOI: 10.1016/j.tcm.2015.03.017

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  6 in total

Review 1.  Roles and indications for use of implantable defibrillator and resynchronization therapy in the prevention of sudden cardiac death in heart failure.

Authors:  Yitschak Biton; Jayson R Baman; Bronislava Polonsky
Journal:  Heart Fail Rev       Date:  2016-07       Impact factor: 4.214

2.  Twenty-First Century Diseases: Commonly Rare and Rarely Common?

Authors:  Sylvia Daunert; Gurusingham Sitta Sittampalam; Pascal J Goldschmidt-Clermont
Journal:  Antioxid Redox Signal       Date:  2017-07-05       Impact factor: 8.401

Review 3.  Studying Cardiac Neural Network Dynamics: Challenges and Opportunities for Scientific Computing.

Authors:  Nil Z Gurel; Koustubh B Sudarshan; Sharon Tam; Diana Ly; J Andrew Armour; Guy Kember; Olujimi A Ajijola
Journal:  Front Physiol       Date:  2022-04-29       Impact factor: 4.755

4.  Effects of Transendocardial Stem Cell Injection on Ventricular Proarrhythmia in Patients with Ischemic Cardiomyopathy: Results from the POSEIDON and TAC-HFT Trials.

Authors:  Archana Ramireddy; Chad R Brodt; Adam M Mendizabal; Darcy L DiFede; Chris Healy; Vishal Goyal; Yahya Alansari; James O Coffey; Juan F Viles-Gonzalez; Alan W Heldman; Jeffrey J Goldberger; Robert J Myerburg; Joshua M Hare; Raul D Mitrani
Journal:  Stem Cells Transl Med       Date:  2017-03-02       Impact factor: 6.940

5.  Cardiac Arrests During the COVID-19 Pandemic: The Perfect Storm.

Authors:  Raul D Mitrani; Jeffrey J Goldberger
Journal:  JACC Clin Electrophysiol       Date:  2020-09-16

6.  Maternally expressed 3 protects the intestinal barrier from cardiac arrest-induced ischemia/reperfusion injury via miR-34a-3p/sirtuin 1/nuclear factor kappa B signaling.

Authors:  Xianwei Huang; Mandong Pan; Penghui Du; Yinrong Chen; Caixia Zhang; Wang Lu; Jiyan Lin
Journal:  Ann Transl Med       Date:  2021-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.